Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
Deloitte
Medtronic
Accenture
Fish and Richardson
Daiichi Sankyo
Teva
Citi
Queensland Health

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020611

« Back to Dashboard

NDA 020611 describes DOVONEX, which is a drug marketed by Leo Pharma As and Leo Pharm and is included in three NDAs. It is available from three suppliers. Additional details are available on the DOVONEX profile page.

The generic ingredient in DOVONEX is calcipotriene. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the calcipotriene profile page.
Summary for 020611
Tradename:DOVONEX
Applicant:Leo Pharm
Ingredient:calcipotriene
Patents:0
Therapeutic Class:Dermatological Agents
Pharmacology for NDA: 020611
Ingredient-typeVitamin D
Suppliers and Packaging for NDA: 020611
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DOVONEX calcipotriene SOLUTION;TOPICAL 020611 NDA Physicians Total Care, Inc. 54868-6057 54868-6057-0 60 mL in 1 BOTTLE, PLASTIC (54868-6057-0)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;TOPICALStrength0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Mar 3, 1997TE:RLD:Yes

Expired US Patents for NDA 020611

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997 ➤ Subscribe ➤ Subscribe
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997 ➤ Subscribe ➤ Subscribe
Leo Pharm DOVONEX calcipotriene SOLUTION;TOPICAL 020611-001 Mar 3, 1997 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Julphar
McKinsey
US Army
Daiichi Sankyo
Moodys
US Department of Justice
Accenture
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot